Cannapharmarx annual operating margin
2024
2025
Cannapharmarx's operating margin was −245.77% for fiscal 2025.
View full Cannapharmarx company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −245.77% | +196.96 pp |
| 2024 | 2024-12-31 | −442.72% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −137.15% | +225.96 pp |
| Q1 2026 | 2026-03-31 | −108.75% | +93.33 pp |
| Q4 2025 | 2025-12-31 | −644.56% | −269.78 pp |
| Q3 2025 | 2025-09-30 | −142.50% | +22.79 pp |
| Q2 2025 | 2025-06-30 | −363.10% | +2695.04 pp |
| Q1 2025 | 2025-03-31 | −202.07% | — |
| Q4 2024 | 2024-12-31 | −374.78% | — |
| Q3 2024 | 2024-09-30 | −165.29% | — |
| Q1 2024 · Mar 31 | 2024-03-31 | −3,058.15% | — |
Across the available reported history, Cannapharmarx's operating margin increased from −442.72% to −245.77%, a change of +196.96 percentage points. The latest reported quarter, Q2 2026, shows −137.15%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cannapharmarx filings at SEC.gov ↗